Additionally, GLP-1 drugs have been shown to lower the risk of major cardiovascular events, such as heart attacks and strokes, in patients with type 2 diabetes, regardless of their impact on blood sugar levels
Choose it for: Regular peptide users and anyone building a long-term firming routine
Theilmann M, Lemp JM, Winkler V, et al
Molecules 25 (17), 3847
Additionally, patients experiencing significant side effects may stop taking their GLP-1 sooner than someone who doesnt experience side effects
Abubakar, Nitesh Kumar, Vinod L Gaikwad, Amita Rai, Krishna Murti Endocrine.2026;[Epub] CrossRef Synthesis, Characterization, and Antidiabetic Evaluation of SequenceModified Liraglutide Analogs in a Drosophila melanogaster Model Tamira Ravi, Kalpanarani Dash, Deep Kumar Barman, Hyukjin Kwon, Monalisa Mishra, Harekrushna Sahoo Biopolymers.2026;[Epub] CrossRef Peptide-functionalized nanoemulsions with exendin-4 as a model ligand Natasa Holler, Bernd Gesslbauer, Carmen Tam-Amersdorfer, Ilse Letofsky-Papst, Claudia Mayrhofer, Fritz Andreae, Andreas Zimmer International Journal of Pharmaceutics: X.2026